Showing results (71-80 of 101) with videos related to
Sort By:
Pageof 11
Journal of the American College of Surgeons|November 20, 2013
Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: a new strategy for hepatic surgeryBin Wang, Chun-Yan Xia, Wan-Yee Lau, et al.Cancer Letters|June 28, 2005
A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infectionZhong-Zheng Zhu, Wen-Ming Cong, Shu-Fang Liu, et al.Journal of Cancer Research and Clinical Oncology|October 16, 2016
Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinomaLong-Hai Feng, Hui Dong, Wan-Yee Lau, et al.Frontiers in Oncology|June 9, 2023
Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomyLong-Hai Feng, Yu-Yao Zhu, Jia-Min Zhou, et al.Plos Biology|October 19, 2018
Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose traffickingGuang-Zhi Jin, Yajuan Zhang, Wen-Ming Cong, et al.Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|December 7, 2005
[Association of p53 codon 72 polymorphism with genetic susceptibility to hepatocellular carcinoma in Chinese population]Zhong-zheng Zhu, Wen-ming Cong, Guan-shan Zhu, et al.World Journal of Surgery|December 25, 2009
Inflammatory myofibroblastic tumor of the liver: a cohort studyLiang Tang, Eric C H Lai, Wen-Ming Cong, et al.Oncology|August 28, 2010
Association of genetic polymorphisms in STAT1 gene with increased risk of hepatocellular carcinomaZhong-Zheng Zhu, Jian-Zhong Di, Wen-Ye Gu, et al.Journal of Gastroenterology|October 22, 2020
Proteomics analysis identified TPI1 as a novel biomarker for predicting recurrence of intrahepatic cholangiocarcinomaWen-Long Yu, Guanzhen Yu, Hui Dong, et al.Annals of Surgical Oncology|September 23, 2022
A Practical Risk Classification of Early Recurrence in Hepatocellular Carcinoma Patients with Microvascular invasion after Hepatectomy: A Decision Tree AnalysisLong-Hai Feng, Yu-Yao Zhu, Jia-Min Zhou, et al.Pageof 11